Table I.
Association between miR-663b expression and clinicopathological characteristics of patients with nasopharyngeal carcinoma.
| Variables | Number (n=67) | Low miR-663b (n=35) | High miR-663b (n=32) | P-value |
|---|---|---|---|---|
| Age | 0.628 | |||
| <55 | 33 | 16 | 17 | |
| ≥55 | 34 | 19 | 15 | |
| Gender | 0.807 | |||
| Male | 36 | 18 | 18 | |
| Female | 31 | 17 | 14 | |
| Grade | 0.225 | |||
| G1-2 | 37 | 22 | 15 | |
| G3 | 30 | 13 | 17 | |
| T stage | 0.089 | |||
| T1-2 | 35 | 22 | 13 | |
| T3-4 | 32 | 13 | 19 | |
| Lymph node metastasis | 0.014 | |||
| No | 38 | 25 | 13 | |
| Yes | 29 | 10 | 19 | |
| Distant metastasis | 0.401 | |||
| No | 50 | 28 | 22 | |
| Yes | 17 | 7 | 10 | |
| Clinical stage | 0.003 | |||
| I–II | 34 | 24 | 10 | |
| III–IV | 33 | 11 | 22 | |
| EBV infection | 1.000 | |||
| No | 5 | 3 | 2 | |
| Yes | 62 | 32 | 30 |